UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.150

Sortiert nach

Somatostatin Receptor Antagonists for Imaging and Therapy

Journal of Nuclear Medicine, 2017-09, Vol.58 (Suppl 2), p.61S-66S

2017

Volltextzugriff (PDF)

GLP-1–Receptor Scanning for Imaging of Human Beta Cells Transplanted in Muscle

The New England journal of medicine, 2010-09, Vol.363 (13), p.1289-1290

2010

Volltextzugriff (PDF)

Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals

Cancers, 2022-02, Vol.14 (5), p.1172

2022

Volltextzugriff (PDF)

Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges

Reviews in endocrine & metabolic disorders, 2021-09, Vol.22 (3), p.581-594

2021

Volltextzugriff (PDF)

Radiolabeled Somatostatin Receptor Antagonists Are Preferable to Agonists for in Vivo Peptide Receptor Targeting of Tumors

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (44), p.16436-16441

2006

Volltextzugriff (PDF)

Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI

PloS one, 2021-06, Vol.16 (6), p.e0253078-e0253078

2021

Volltextzugriff (PDF)

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT

Journal of Nuclear Medicine, 2010-07, Vol.51 (7), p.1059-1067

2010

Volltextzugriff (PDF)

Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas

Journal of Nuclear Medicine, 2011-07, Vol.52 (7), p.1073-1078

2011

Volltextzugriff (PDF)

Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors

Journal of hepato-biliary-pancreatic sciences, 2021-09, Vol.28 (9), p.727-739

2021

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study

The lancet. Diabetes & endocrinology, 2013-10, Vol.1 (2), p.115-122

2013

Volltextzugriff (PDF)

Improvement of Lung NET Management through Standardized Care-A Swiss Nationwide Observational Study

Cancers, 2023-04, Vol.15 (8), p.2270

2023

Volltextzugriff (PDF)

Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors

Cancers, 2022-07, Vol.14 (14), p.3317

2022

Volltextzugriff (PDF)

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study

EJNMMI research, 2024-04, Vol.14 (1), p.37-37, Article 37

2024

Volltextzugriff (PDF)

Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies

Frontiers in endocrinology (Lausanne), 2023-02, Vol.14, p.1095815

2023

Volltextzugriff (PDF)

Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients

Cancers, 2021-12, Vol.13 (24), p.6290

2021

Volltextzugriff (PDF)

Non-invasive nuclear myocardial perfusion imaging improves the diagnostic yield of invasive coronary angiography

European heart journal cardiovascular imaging, 2015-08, Vol.16 (8), p.842-847

2015

Volltextzugriff (PDF)

Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor

Case reports in oncology, 2020-11, Vol.13 (3), p.1373-1380

2020

Volltextzugriff (PDF)

Accuracy comparison of various quantitative [99mTc]Tc-DPD SPECT/CT reconstruction techniques in patients with symptomatic hip and knee joint prostheses

EJNMMI research, 2021-06, Vol.11 (1), p.60-60, Article 60

2021

Volltextzugriff (PDF)

Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging

Case reports in endocrinology, 2020, Vol.2020, p.4510910-4

2020

Volltextzugriff (PDF)

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 Is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor–Targeted Therapy for Insulinoma

Clinical cancer research, 2007-06, Vol.13 (12), p.3696-3705

2007

Volltextzugriff (PDF)

Comparison of [18F]FDG PET/CT with magnetic resonance imaging for the assessment of human brown adipose tissue activity

EJNMMI research, 2020-07, Vol.10 (1), p.85-85, Article 85

2020

Volltextzugriff (PDF)

New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting

Clinical cancer research, 2008-04, Vol.14 (7), p.2019-2027

2008

Volltextzugriff (PDF)

1 – 25 von 1.150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(298)

Publikationsform

Sprache

Englisch
(1.150)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Somatostatin Receptor Antagonists for Imaging and Therapy

GLP-1–Receptor Scanning for Imaging of Human Beta Cells Transplanted in Muscle

Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals

Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges

Radiolabeled Somatostatin Receptor Antagonists Are Preferable to Agonists for in Vivo Peptide Receptor Targeting of Tumors

Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT

Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas

Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors

Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study

Improvement of Lung NET Management through Standardized Care-A Swiss Nationwide Observational Study

Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors

Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study

Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies

Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients

Non-invasive nuclear myocardial perfusion imaging improves the diagnostic yield of invasive coronary angiography

Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor

Incremental Value of a Single High-sensitivity Cardiac Troponin I Measurement to Rule Out Myocardial Ischemia

Accuracy comparison of various quantitative [99mTc]Tc-DPD SPECT/CT reconstruction techniques in patients with symptomatic hip and knee joint prostheses

Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging

Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 Is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor–Targeted Therapy for Insulinoma

Comparison of [18F]FDG PET/CT with magnetic resonance imaging for the assessment of human brown adipose tissue activity

New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting

Suchergebnisse filtern